Hudson Valley Investment Advisors Inc Gilead Sciences, Inc. Transaction History

Hudson Valley Investment Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $198,571 - $259,120	-3,280 Closed	0 $0
Q2 2018 Jul 10, 2018	SELL	$64.88 - $75.68 $15,571 - $18,163	-240 Reduced 6.82%	3,280 $232,000
Q1 2018 Apr 12, 2018	SELL	$72.84 - $88.8 $75,025 - $91,464	-1,030 Reduced 22.64%	3,520 $265,000
Q4 2017 Jan 16, 2018	SELL	$71.15 - $83.52 $168,625 - $197,942	-2,370 Reduced 34.25%	4,550 $326,000
Q3 2017 Oct 13, 2017	BUY	$72.11 - $85.47 $499,001 - $591,452	6,920	6,920 $561,000

1,941

989M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hudson Valley Investment Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Hudson Valley Investment Advisors Inc with notifications on news.